Science Explorer Back to mapMap
Discussion
Researcher · Simcere Pharmaceutical (China) · China

Yayuan Fu

Yayuan Fu publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, on topics such as Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and Cancer Research and Treatments.

OpenAlex
World rank
#5,229,834
of 7,710,434 ranked researchers
Rank in China
#772,124
of 978,568
Works
18
Citations
16
Citations per work
0.9
h-index
1
i10-index 1Top 99.6% in Oncology
Yayuan Fu

What does Yayuan Fu research?

Yayuan Fu's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (20%), Engineering (4%).

Health Sciences: 10 works · 57.1% of their workMedicine: 10 works · 57.1% of their workOncology: 6 works · 30.6% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 20.4% of their workPulmonary and Respiratory Medicine: 1 works · 6.1% of their workLife Sciences: 4 works · 20.4% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 20.4% of their workMolecular Biology: 3 works · 14.3% of their workBiotechnology: 1 works · 6.1% of their workEverything else: 3 works · 18.4% of their workPhysical Sciences: 1 works · 4.1% of their workEngineering: 1 works · 4.1% of their workBiomedical Engineering: 1 works · 4.1% of their workTHEIR WORKYayuan Fu18works
Life Sciences20%Physical Sciences4%Health Sciences57%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1057.1%
    1. Biochemistry, Genetics and Molecular Biology420.4%
  3. Everything else318.4%
    1. Engineering14.1%
  1. 1Oncology31% of their works
  2. 2Radiology, Nuclear Medicine and Imaging20% of their works
  3. 3Molecular Biology14% of their works
  4. 4Biotechnology6% of their works
  5. 5Pulmonary and Respiratory Medicine6% of their works
  6. 6Biomedical Engineering4% of their works

Research topics

Which keywords describe Yayuan Fu's research?

The keywords of their largest research topics: Glycosylation, Chemotherapy, Fc Receptors, Immunotherapy, Therapeutic Antibodies, Breast Cancer, Cancer and HER2.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Glycosylation102 topics
  2. Chemotherapy82 topics
  3. Fc Receptors81 topic
  4. Immunotherapy83 topics
  5. Therapeutic Antibodies81 topic
  6. Breast Cancer51 topic
  7. Cancer52 topics
  8. HER251 topic
  9. Tumor Targeting52 topics
  10. Arginine Deprivation31 topic
  11. Bacterial Therapy31 topic
  12. FGF2131 topic
  13. Fibroblast Growth Factor31 topic
  14. Genomic Profiles31 topic
  15. Small-Cell Lung Cancer31 topic
  16. Glycans21 topic
  17. Immune Checkpoint Blockade21 topic
  18. Immune System21 topic
  19. Nanoparticles21 topic
  20. PD-1 and PD-L121 topic
  21. Photothermal Therapy21 topic

Where does Yayuan Fu work?

Yayuan Fu's main affiliation in the publication record is Simcere Pharmaceutical (China), China.

How many publications and citations does Yayuan Fu have?

OpenAlex counts 18 works and 16 citations for Yayuan Fu, an h-index of 1, ranking #5,229,834 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Yayuan Fu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.